After a double lung transplant, a 15-year-old British teen was struck by a life-threatening infection that was resistant to antibiotics. Turning to an experimental therapy, doctors injected her with genetically modified bacteria-eating viruses, or bacteriophages. It was the first time the treatment, known as phage therapy, was used on this kind of bacteria, and a year later the patient is alive and well.
Will phage therapy go mainstream? It requires further testing, but researchers hope this “historic” success could lead to new tools to fight the growing threat of antibiotic-resistant infections.
Check out this OZY story about real-time diagnostics soothing patients’ concerns.